CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 106 enrolled
Drug / intervention
Continuous non-invasive hemoglobin monitoringdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01906515
NCT01906515N/ACompleted
CompareCT.gov

Continuous and Noninvasive Hemoglobin Monitoring Reduces Red Blood Cell Transfusion During Neurosurgery: A Prospective Cohort Study

Cairo University·interventional·Posted Jul 24, 2013·Updated Feb 27, 2014

In Brief

A clinical study evaluating Continuous non-invasive hemoglobin monitoring for Anemia. Completed, enrolled 106 participants.

Detailed Summary

Continuous and noninvasive hemoglobin (SpHb) monitoring provides clinicians with real-time trending of changes or lack of changes in hemoglobin, which has the potential to alter red blood cell (RBC) transfusion decision making. The objective of this study was to evaluate the impact of SpHb monitoring on RBC transfusions in high blood loss surgery. The investigators hypothesize that SpHb will improve blood transfusion practice in the for of change the number of blood unit per patient and improve the outcome regards the time to take decision of transfusion trigger.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnemia
Countries--
CollaboratorsMasimo Corporation

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJul 24, 2013
Enrollment StartFeb 1, 2012
Primary CompletionOct 1, 2012
Study CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 12.9 years ago

Interventions

Continuous non-invasive hemoglobin monitoringdevice

Anesthesiologist is provided with real-time continuous non-invasive hemoglobin monitoring to influence care provided to patient